Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BOSTON, MA--(Marketwired - Mar 11, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today...
-
BOSTON, MA--(Marketwired - Feb 27, 2014) - Marina Biotech, Inc. (OTC Pink: MRNA), a leading oligonucleotide-based drug discovery and development company focused on rare diseases, announced...
-
BOSTON, MA--(Marketwired - Feb 24, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company focused on rare diseases, announced today...
-
BOSTON, MA--(Marketwired - Jan 23, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that a decision to grant a...
-
BOSTON, MA--(Marketwired - Jan 14, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that the Canadian...
-
BOSTON, MA--(Marketwired - Jan 9, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today the grant and issuance of...
-
BOSTON, MA--(Marketwired - Jan 3, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that Philip C. Ranker will...
-
BOSTON, MA and AUSTIN, TX--(Marketwired - Jan 2, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics,...
-
CAMBRIDGE, MA--(Marketwired - Aug 14, 2013) - Marina Biotech, Inc. (PINKSHEETS: MRNA) Assigns Unlocked Nucleobase Analog (UNA) patents to Arcturus but retains...
-
BOTHELL, WA--(Marketwired - May 13, 2013) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the...